Thomas M. Ross - Mar 15, 2024 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
MXCT
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4
Date filed
3/19/2024, 06:21 PM
Previous filing
Apr 12, 2023
Next filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Award $0 +25K $0.00 25K Mar 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Award $0 +100K $0.00 100K Mar 15, 2024 Common Stock 100K $4.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F2 Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.